Company / Operating Cash Flow
AYTU BIOPHARMA, INC Operating Cash Flow History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$1.9M
FY2025
5-year range
-$28.8M / -$1.4M
FY2021-FY2025
Trend
-39.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$29M in FY2022 to -$1M in FY2024.
Based on SEC 10-K filings.
-$2M in FY2025.
Improved from -$5M to -$2M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 39.6% year-over-year.
- Peak operating cash flow was recorded in FY2024.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.9M | -39.6% |
| FY2024 | -$1.4M | +72.9% |
| FY2023 | -$5.1M | +82.2% |
| FY2022 | -$28.8M | -11.0% |
| FY2021 | -$26.0M | +8.5% |
| FY2020 | -$28.4M | -78.0% |
| FY2018 | -$15.9M | -15.3% |
| FY2017 | -$13.8M | -29.8% |
| FY2016 | -$10.7M | -60.6% |
| FY2015 | -$6.6M | -1950.8% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026